Modelling alternative strategies for delivering hepatitis B vaccine in prisons: the impact on the vaccination coverage of the injecting drug user population

Other literature type, Article English OPEN
SUTTON, A. J. ; GAY, N. J. ; EDMUNDS, W. J. ; GILL, O. N. (2008)
  • Publisher: Cambridge University Press
  • Related identifiers: doi: 10.1017/S0950268808000502
  • Subject: Original Papers
    mesheuropmc: behavioral disciplines and activities | social sciences | virus diseases | population characteristics | mental disorders

SUMMARYSince 2001 hepatitis B vaccination has been offered to prisoners on reception into prisons in England and Wales. However, short campaigns of vaccinating the entire population of individual prisons have achieved high vaccination coverage for limited periods, suggesting that short campaigns may be a preferable way of vaccinating prisoners. A model is used that describes the flow of prisoners through prisons stratified by injecting status to compare a range of vaccination scenarios that describe vaccination on prison reception or via regular short campaigns. Model results suggest that vaccinating on prison reception can capture a greater proportion of the injecting drug user (IDU) population than the comparable campaign scenarios (63% vs. 55.6% respectively). Vaccination on prison reception is also more efficient at capturing IDUs for vaccination than vaccination via a campaign, although vaccination via campaigns may have a role with some infections for overall control.
  • References (14)
    14 references, page 1 of 2

    1. Health Protection Agency, Health Protection Scotland, National Public Health Service for Wales, CDSC Northern Ireland, CRDHB, and UASSG. Shooting up ; infections among injecting drug users in the United Kingdom 2004 : an update, October 2005. London : Health Protection Agency, 2005.

    2. Health Protection Agency ( Accessed December 2006.

    3. Weild AR, et al. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales : a National Survey. Communicable Disease and Public Health 2000 ; 3 : 121-126.

    4. Sutton AJ, et al. Modelling the hepatitis B vaccination programme in prisons. Epidemiology and Infection 2006 ; 134 : 231-242.

    5. Gore SM, et al. Anonymous HIV surveillance with risk-factor elicitation : at Perth (for men) and Cornton Vale (for women) prisons in Scotland. International Journal of STD & AIDS 1997 ; 3 : 166-175.

    6. Allwright S, et al. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners : results of a national cross sectional survey. British Medical Journal 2000 ; 321 : 78-82.

    7. Vong S, et al. Vaccination in the county jail as a strategy to reach high risk adults during a community-based hepatitis a outbreak among methamphetamine drug users. Vaccine 2005 ; 23 : 1021-1028.

    8. Gilbert RL, et al. Hepatitis A vaccination - a prisonbased solution for a community-based outbreak ? Communicable Disease and Public Health 2004 ; 7 : 289-293.

    9. Gilbert RL, et al. Increasing hepatitis B vaccine coverage in prisons in England and Wales. Communicable Disease and Public Health 2004 ; 7 : 306-311.

    10. Hutchinson SJ, et al. Sudden rise in uptake of hepatitis B vaccination among injecting drug users associated with a universal vaccine programme in prisons. Vaccine 2004 ; 23 : 210-214.

  • Metrics
    No metrics available
Share - Bookmark